283 related articles for article (PubMed ID: 20969959)
21. Effects of pravastatin and atorvastatin on HDL cholesterol and glucose metabolism in patients with dyslipidemia and glucose intolerance: the PRAT study.
Sasaki J; Otonari T; Uchida Y; Ikeda Y; Biro S; Kono S;
J Atheroscler Thromb; 2013; 20(4):368-79. PubMed ID: 23257975
[TBL] [Abstract][Full Text] [Related]
22. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
Chen GP; Yao L; Lu X; Li L; Hu SJ
Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
[TBL] [Abstract][Full Text] [Related]
23. The effect of pravastatin and atorvastatin on coenzyme Q10.
Bleske BE; Willis RA; Anthony M; Casselberry N; Datwani M; Uhley VE; Secontine SG; Shea MJ
Am Heart J; 2001 Aug; 142(2):E2. PubMed ID: 11479481
[TBL] [Abstract][Full Text] [Related]
24. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
[TBL] [Abstract][Full Text] [Related]
25. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
[TBL] [Abstract][Full Text] [Related]
26. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin.
Murrow JR; Sher S; Ali S; Uphoff I; Patel R; Porkert M; Le NA; Jones D; Quyyumi AA
J Clin Lipidol; 2012; 6(1):42-9. PubMed ID: 22264573
[TBL] [Abstract][Full Text] [Related]
27. Atorvastatin induces thrombomodulin expression in the aorta of cholesterol-fed rabbits and in TNFalpha-treated human aortic endothelial cells.
Lin SJ; Hsieh FY; Chen YH; Lin CC; Kuan II; Wang SH; Wu CC; Chien HF; Lin FY; Chen YL
Histol Histopathol; 2009 Sep; 24(9):1147-59. PubMed ID: 19609862
[TBL] [Abstract][Full Text] [Related]
28. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature.
Parker RA; Huang Q; Tesfamariam B
Atherosclerosis; 2003 Jul; 169(1):19-29. PubMed ID: 12860247
[TBL] [Abstract][Full Text] [Related]
29. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
Martínez-González J; Alfón J; Berrozpe M; Badimon L
Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203
[TBL] [Abstract][Full Text] [Related]
30. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats.
Roglans N; Sanguino E; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
J Pharmacol Exp Ther; 2002 Jul; 302(1):232-9. PubMed ID: 12065722
[TBL] [Abstract][Full Text] [Related]
31. Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects.
Tannous M; Cheung R; Vignini A; Mutus B
Thromb Haemost; 1999 Nov; 82(5):1390-4. PubMed ID: 10595624
[TBL] [Abstract][Full Text] [Related]
32. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide.
Gao YJ; Lu C; Su LY; Sharma AM; Lee RM
Br J Pharmacol; 2007 Jun; 151(3):323-31. PubMed ID: 17384669
[TBL] [Abstract][Full Text] [Related]
33. Physicochemical modifications induced by statins therapy on human erythrocytes membranes.
Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J
Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550
[TBL] [Abstract][Full Text] [Related]
34. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial.
Päivä H; Thelen KM; Van Coster R; Smet J; De Paepe B; Mattila KM; Laakso J; Lehtimäki T; von Bergmann K; Lütjohann D; Laaksonen R
Clin Pharmacol Ther; 2005 Jul; 78(1):60-8. PubMed ID: 16003294
[TBL] [Abstract][Full Text] [Related]
35. Coenzyme Q10 supplementation improves metabolic parameters, liver function and mitochondrial respiration in rats with high doses of atorvastatin and a cholesterol-rich diet.
Jiménez-Santos MA; Juárez-Rojop IE; Tovilla-Zárate CA; Espinosa-García MT; Juárez-Oropeza MA; Ramón-Frías T; Bermúdez-Ocaña DY; Díaz-Zagoya JC
Lipids Health Dis; 2014 Jan; 13():22. PubMed ID: 24460631
[TBL] [Abstract][Full Text] [Related]
36. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase.
Ohira M; Endo K; Saiki A; Miyashita Y; Terai K; Murano T; Watanabe F; Tatsuno I; Shirai K
Metabolism; 2012 Oct; 61(10):1452-60. PubMed ID: 22520230
[TBL] [Abstract][Full Text] [Related]
38. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
39. Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells.
Ishikawa M; Okajima F; Inoue N; Motomura K; Kato T; Takahashi A; Oikawa S; Yamada N; Shimano H
J Atheroscler Thromb; 2006 Dec; 13(6):329-35. PubMed ID: 17192698
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of contractile dysfunction by atorvastatin after intestinal ischemia reperfusion injury in rats.
Ozacmak VH; Sayan H; Igdem AA; Cetin A; Ozacmak ID
Eur J Pharmacol; 2007 May; 562(1-2):138-47. PubMed ID: 17335801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]